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Özet
Amaç: Ereksiyon bozukluğu olan erkeklerde obstruktif uyku bozukluğunun te-
davi edilmesinin seksüel performans üzerine olan iyileştirici etkisini araştır-
mayı amaçladık. Gereç ve Yöntem: Ereksiyon bozukluğu ve obstruktif uyku bo-
zukluğu ile başvuran 141 hasta için IIEF (uluslararası ereksiyon indeksi) formu 
dolduruldu ve uyku laboratuvarında değerlendirildi. Bütün hastaların kulak 
burun boğaz muayenesi yapıldı. Cerrahi ve CBAP(continuous positive airway 
pressure) tedavisi yapılan hastalar apne-hipopne indeksine (AHI) göre değer-
lendirildi.  Erken dönem 3. ayda apne tedavisi ve sonuçları tamamlanan 23 
hastaya IIEF formları tekrar doldurtularak skorlaması yapılmıştır Hastaların 
yaşları 26 ile 65 arasında değişmekteydi. Tedavi öncesi ve sonrasındaki IEEF 
skorundaki farklılıkların değerlendirilmesinde Wilcoxon signed ranks, Kruskal 
Wallis, Spearman’s rho testleri kullanıldı. Bulgular: IIEF skorunda anlamlı dü-
zelme tespit edilen 23 hastanın tedavi öncesine göre IIEF skorlarındaki dü-
zelmenin istatistiksel olarak anlamlı olduğu izlendi (p<0.001). Tedavi öncesi 
ve sonrasında IIEF puanlarındaki değişim ile AHİ, tedavi yöntemi, hasta yaşı 
ve vücut kitle indeksi arasında anlamlı bir ilişki saptanmamıştır (p> 0.05). 
Tartışma: Uyku apnesi yakınması olan hastalarda seksüel performansta da 
gerileme olabileceği ve apne tedavisi ile performansta belirgin bir düzelme 
olduğu saptanmıştır.
Anahtar Kelimeler
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Abstract
Aim: We aimed to investigate the effect of obstructive sleep apnea treatment 
on sexual performance in the case of obstructive sleep apnea in men with 
erectile  dysfunction.  Material  and  Method:  IIEF  (international  index  of 
erectile function ) form was filled for 141 male patients who admitted with 
obstructive  sleep  apnea  and  with  erectile  dysfunction  and  investigated 
in  polysomnography  laboratory.  All  patients  were  examined  at  ENT  (Ear 
Nose and Throat ) clinic. Patients in the treatment of surgery and CBAP 
(continuous positive airway pressure) were evaluated according to the apne-
hipopne index (AHI). Preliminary report has been done at the 3. month after 
the OSAS(Obstructive Sleep Apnea Syndrome) therapy for the 23 patients. 
IIEF form was filled again and symptom scoring has been updated for 23 
patients who could be followed after sleep apnea treatment. The age of 
these patients ranged from 26 to 65 years. Wilcoxon signed ranks, Kruskal 
Wallis, and Spearman’s rho tests were used to evaluate differences in IIEF 
scores  before  and  after  the  treatment.  Results:  Significant  improvement 
were confirmed at IIEF scores of 23 patients with obstructive sleep apnea 
who could be followed and treated statistically (p<0.001). The difference 
in IIEF scores before and after treatment were not associated with AHI, 
treatment  methods,  patient  age  and  BMI  (p>0.05).  Discussion:  Sexual 
performance may decline in patients with obstructive sleep apnea and a 
significant improvement was detected on sexual performance with apnea 
treatment in this group of patients.
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Introduction 
Obstructive sleep apnea (OSA) is the most prevalent sleep dis-
order affecting 2.2–4.8% of men [1]. It is characterized by peri-
ods of functional obstruction of the upper airway during sleep, 
resulting in decreases in arterial oxygen saturation and tran-
sient arousals. The major symptoms associated with OSA are 
excessive daytime sleepiness and loud snoring, fatigue, gasping, 
nocturia,  nocturnal  sweating,  morning  headaches,  heartburn 
and erectile dysfunction [2-7]. In this study our starting point 
was to point out whether if the sexual performance of sleep 
apne patients is affected or not. The second point was to show 
whether if the sexual performance improved after the sleep ap-
nea therapy.
Material and Method
All patients were signed consent forms in order to participate in 
the study. Polysomnographic study was performed during two 
consecutive nights and CPAP titrations were done another day. 
At least 7 hours of sleep was recorded. Patients were also per-
formed electroencephalography (EEG), electroculography (EOG), 
electromiyography (EMG) and electrocardiography (ECG). Inha-
lation of the patients was followed up with a nasal cannula. 
Polysomnography results were evaluated according to the clas-
sification criterias of the American Sleep Academy. Respiratory 
arrest for at least 10 seconds or more was defined as apnea, 
while reduction of the 50% of breathing for at least 10 sec-
onds was defined as hypopnea. Total of apnea and hypopnea 
episodes in one hour was considered as apnea-hypopnea index 
(AHI). Patients in our study were diagnosed as OSAS according 
to AHI and 5-14 was considered as mild, while 15-30 and > 30 
were considered as moderate and severe, respectively [8]. 
IIEF-5 scoring was performed by a single urologist. High score 
means better erection function. Classification of ED (Erectile 
Dysfunction) was defined as follows: score between 5-7 as se-
vere ED, score between 8-11 as moderate ED, score between 
12-16 as mild-moderate ED, score between 17-21 as mild ED 
and score between 22-25 as normal erectile function [9].  All 
biochemical and hormonal analysis were done and patients with 
abnormal values were excluded.  Patients who had nitrate us-
ing, hormonal disorder, neuropathical and neurological disease, 
prostate  cancer,  pelvic  trauma  history,  renal  transplantation 
surgery, aortic aneurysm, spinal cord injury, endocrine disorder, 
penile deformity, alcohol dependence, psychotropic drug use, 
acute and chronic psychiatric illness, chronic disease, cardio-
vascular disease and metabolic disease were excluded from the 
study.
All patients were examined at Ear Nose and Throat (ENT) clin-
ics. Surgery (UPF:uvuloplatal flep), radiofrequency ablation (RF) 
of the soft palate or continuous positive airway pressure (CPAP) 
treatment was recommeneded according to apne-hipopne index 
(AHI: Apnea and Hypopnea instances per hour) and examination 
of patients. The third month results of 23 patients of these 141 
OSAS patients with poor sexual performance were recorded. 
Approval of  our institutional research committee for this work 
is taken.
Statistical analysis 
Statistical evaluation was applied on Windows SPSS-11.5. When 
scatter of data was examined on SPSS program, normality of 
data was controlled with tests and graphical scatter. As the 
scatter of data was not normal, Wilcoxon signed ranks, Kruskal 
Wallis tests and non-parametric tests were applied. Wilcoxon 
signed ranks, Kruskal Wallis tests and non-parametic statistics 
were used to evaluate differences in IIEF scores before and af-
ter the treatment. p<0.001 was considered as significant.
Results
Our study was initiated with a total of 141 patients. Of these 
141, mean age was 46.34±21.2 years (26-84), mean height was 
168.94±6.15cm, mean weight was 89.23±16.25 kg, mean BMI 
was 31.30±4.75 and mean AHI score was 58.5±21.7 (5.7-126.8). 
85 patients (60.29%) were performed CPAP, 29 (20.56%) were 
performed UPF (uvuloplatal flap) surgery, 15 (10.64%) were per-
formed RF (radiofrequency ablation) and 12 (8.51%) were per-
formed of the IOD (intra-oral device-medical device for mouth 
breathing). We reported the early third month results of 23 pa-
tients. The final results of this ongoing study will be notified 
later.
The mean AHI of these 23 patients was 48.83 ± 32.52 and 4 had 
mild, 5 had moderate and 14 had severe OSAS according to AHI. 
16 of them (69.56%) were performed CPAP, 5 were performed 
RF (21.73%) and 2 were performed UPF surgery (uvuloplatal 
flap surgery) (8.69%).  Pre-treatment maximum, minimum and 
mean IIEF scores were 45, 20 and 32.43 ± 6.75, respectively. 
After the treatment, maximum, minimum and mean IIEF scores 
were 45, 36 and 33.95 ± 4.85, respectively. The difference be-
tween the IIEF scores before and after treatment was statis-
tically significant (p <0.05). On the other hand, there was no 
statistically significant relationship between age, BMI, severity 
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of the disease and treatment options (p>0.05) (Table 1,2,3 and 
Figure 2). Treatment modalities; determined by ENT inspection 
findings and disease severity; were shown in Figure1
Discussion
Obstructive  sleep  apnea  syndrome  is  an  important  disease 
which develops due to reoccurring disorders (apnea, hypopnea) 
as a result of blocked upper air route during sleep [10]. Studies 
showed that there is a relationship between OSAS and sexual 
dysfunction [7]. In fact, sleep and erectile function, even in rela-
tion to each other very closely, are two intertwined functions. 
Nocturnal erection, which is important in erection patophysi-
ology, prominently encompasses the REM phase of the sleep. 
Sleep-related  nocturnal  erections,  called  as  Nocturnal  Penile 
Tumescence (NPT), mainly occur in REM sleep [11]. Presence 
of high sympathetic activity in patients with OSAS, especially 
at night, could prevent the physiological mechanisms of normal 
erection [12]. Penile growth by filling of blood and increase in 
partial oxygen pressure occurs during the NPT. Therefore, NPT 
is believed to be an internal mechanism to protect morphologi-
cal feature of corpora cavernous [13]. Men have 3-5 episodes of 
NPT per night, which take approximately 30-60 minutes [14].
 On the other hand, some of the previous studies demonstrated 
that nocturnal LH and testosterone levels in patients with OSAS 
were significantly lower than the control group. The relationship 
between ED and pituitary-gonadal axis in sleep disorders was 
evaluated and showed that OSAS affects sexual performance 
and causes problems [15].Low plasma levels of nitric oxide (NO), 
an important vasodilator which plays role in the physiology of 
erection, is responsible for ED in patients with OSAS, as well as 
vascular diseases [16]. Additionally, it was shown that hypoxia 
increased the level of endothelin, a potent vasoconstrictor, in 
patients with OSAS [17]. Possible mechanisms explaining the 
relationship  between  erectile  dysfunction  and  sleep  disorder 
were summarized  as follows: depending on exchange in the 
pituitary-gonadal axis leading to a decrease in LH, testosterone 
levels and increase in sympathetic activity, rising norepineph-
rine levels and peripheral nerve dysfunction, in association with 
nocturnal hypoxia,  suppression of no production by oxidative 
stress, in response to acetylcholine and  increased production of 
endothelin, leading to vasoconstriction and antagonizing penile 
tumescence [18].
OSAS can be defined according to apnea-hypopnea index. Ap-
nea-Hypopnea Index is a parameter used in diagnosing OSAS 
which also indicates the severity of the disease as light AHI 
5-14, mild AHI 15-30, strong AHI>30 [8]. In our study we have 
observed that there was a significant sexual performance in-
crease for the patients coming in early phase 3rd month con-
trols who, according to AHI have been diagnosed OSAS and who 
have received ASAS treatment (Surgery (UPF), RF of the soft  
palate or CPAP). However, no significant difference in terms of 
superiority of treatment options to each other may probably be 
due to lower number of patients in RF group. We hope that the 
number of patients in treatment groups will be sufficient for the 
evaluation of late-term results.
CPAP  therapy  and  nocturnal  hypoxemia  (the  lowest  oxygen 
saturation measured at night) was determined the most sig-
nificant variable with ED. Efficacy of CPAP may be occurring 
via increasing circulating levels of NO [19]. CPAP therapy also 
reduced the level endothelin by reducing hypoxia [4]. Significant 
improvements in erectile function with CPAP therapy in OSAS 
patients was first reported by Karacan and Karatas in 1995 [20]. 
On the other hand, in recent studies, significant improvements 
in erectile function with CPAP therapy have been reported sig-
nificant  post-treatment  improvements  in  the  lowest  oxygen 
saturation and IIEF scores [21,22]. In our study, the majority of 
patients underwent CPAP therapy and then IIEF scores before 
and after treatment were compared and statistically significant 
difference was determined. In recent years, safety and efficacy 
of sildenafil treatment in erectile dysfunction of OSAS patients 
have been reported in studies [23,24]. The addition of paren-
teral testosterone therapy in patients with OSAS and hypogo-
nadism have been reported more beneficial in improvement of 
erectile function [25].
In this pilot study, we observed that patients with OSAS and 
high AHI often had moderate and high IIEF symptom scores. We 
also detected that even only treating OSAS with no need for any 
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additional medical treatment may lead to a satisfactory sexual 
performance improvement. In our study, changes in IIEF scores 
in patients with OSAS before and after treatment and the re-
lationship between age, body mass index, severity of disease 
(AHI) and treatment modalities was not statistically significant. 
Although minimum and maximum values of IIEF score before 
treatment were higher than after treatment values , median 
value was higher after treatment and this elevation was statis-
tically significant.
It was detected that sexual performance can also be deteriorat-
ed and significant improvement in performance can be provided 
by the treatment of apnea in patients with sleep apnea in this 
study. We suggest that treatment of OSAS should be considered 
besides medical treatment for the improvement of sexual func-
tion in patients with OSAS with erectile dysfunction. 
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